Glenmark set to launch FabiFlu 400mg for Covid-19 treatment in India
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetails
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals said Wedensday that the Phase 3 clinical trial of antiviral drug Favipiravir is giving hope. Glenmark ...
Read moreDetailsNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetails
Tensions between the US and Venezuela have reached a seemingly critical level over what the US administration ostensibly calls its...
Read moreDetails
Despite the newfound bonhomie between China and India in the wake of US President Donald Trump’s tariff war, China is...
Read moreDetails
In its latest annual review, the International Monetary Fund (IMF) has assigned a ‘C’ grade to India’s national accounts statistics...
Read moreDetails
Last month, along with Pakistan and Iraq, India was elected to the UN Human Rights Council from Asia. The UNHRC...
Read moreDetails
